1.
Jacobsen IC, Berg T, Jensen M-B, Knop AS. Outcomes for patients with high-risk ER-positive, HER2-negative early-stage breast cancer: a Danish real-world study. AO [Internet]. 2025 Nov. 12 [cited 2026 May 27];64:1531-9. Available from: https://medicaljournalssweden.se/actaoncologica/article/view/44003